Zuellig Pharma Executive and Leadership Team

John Chou, the Chief Executive Officer at Zuellig Pharma, directs the overarching corporate strategy to expand healthcare accessibility across the Asian market. By overseeing the integration of distribution networks and digital service platforms, the Chief Executive Officer ensures alignment with the long-term mission of improving patient outcomes. This leadership role involves constant collaboration with the Board to refine market positioning and drive sustainable growth. John Chou maintains a focus on operational excellence, ensuring that the company remains a leader in healthcare services. Through the implementation of robust business models, the Chief Executive Officer optimizes resource allocation across diverse regional markets. By fostering partnerships with global pharmaceutical manufacturers, the Chief Executive Officer strengthens the supply chain infrastructure. Ultimately, Chou secures the company's competitive advantage by prioritizing innovation and service quality in every aspect of the healthcare ecosystem.

Evasio Barbero, the Chief Financial Officer at Zuellig Pharma, manages the fiscal health and capital allocation strategies necessary for supporting extensive healthcare distribution networks. Overseeing financial planning and analysis, the Chief Financial Officer ensures that investments in digital services and commercial infrastructure yield maximum returns. This role requires rigorous oversight of regional financial reporting to maintain transparency and compliance across diverse Asian markets. Evasio Barbero collaborates with the executive team to mitigate financial risks while identifying new opportunities for revenue growth. By optimizing cost structures and capital efficiency, the Chief Financial Officer supports the broader organizational goal of providing affordable healthcare solutions. Through disciplined financial management, Barbero drives the company's ability to scale operations effectively. Ultimately, the Chief Financial Officer maintains the fiscal stability required to sustain long-term growth and market leadership in the competitive healthcare services sector.

Andrew Khoo, the Chief Financial Officer, & Brunei (Malaysia) at Zuellig Pharma, manages the financial operations and fiscal strategy specifically for the Malaysia and Brunei markets. Overseeing regional budgeting, tax compliance, and financial reporting, the Chief Financial Officer, & Brunei (Malaysia) ensures that local operations remain profitable and aligned with corporate objectives. This role involves analyzing market-specific financial trends to support strategic decision-making in these key territories. Andrew Khoo collaborates with regional leadership to optimize resource allocation and drive growth in the local healthcare sector. By maintaining strict financial controls, the Chief Financial Officer, & Brunei (Malaysia) supports the company's broader mission of providing reliable healthcare services. Through the effective management of regional assets, Khoo ensures the financial health of the business in these specific markets. Ultimately, the Chief Financial Officer, & Brunei (Malaysia) secures the fiscal foundation necessary for sustained success in Malaysia and Brunei.

Aylie Widjaja, the Chief Operating Officer at Zuellig Pharma, directs the daily logistics and supply chain operations that underpin the company's healthcare distribution services. Overseeing the physical movement of medical products, the Chief Operating Officer ensures that regional operations meet the highest standards of quality and safety. This role involves managing complex warehouse networks and transportation systems to guarantee timely delivery to healthcare providers across Asia. Aylie Widjaja collaborates with the executive team to streamline operational processes and improve service reliability. By focusing on internal scaling and process optimization, the Chief Operating Officer enhances the company's ability to handle increasing demand for pharmaceutical products. Through the implementation of rigorous operational protocols, Widjaja maintains the integrity of the supply chain. Ultimately, the Chief Operating Officer drives the efficiency and effectiveness of the company's core distribution business, ensuring consistent support for healthcare needs.

Yvonne Cheah, the Chief Operating Officer, Clinical Trial Support at Zuellig Pharma, manages the specialized operations required to facilitate clinical research and trial logistics. Overseeing the coordination of trial materials and patient-centric services, the Chief Operating Officer, Clinical Trial Support ensures that research initiatives proceed with precision and regulatory compliance. This role involves managing the unique supply chain requirements for clinical trials, including cold-chain logistics and specialized handling. Yvonne Cheah collaborates with pharmaceutical partners to provide the infrastructure necessary for successful drug development across the region. By optimizing trial support services, the Chief Operating Officer, Clinical Trial Support enables faster and more reliable research outcomes. Through the application of industry-specific expertise, Cheah ensures that the company remains a trusted partner in the clinical research space. Ultimately, the Chief Operating Officer, Clinical Trial Support drives the growth of the company's specialized research services division.

Dr Franck, the President of Korea Companies at Zuellig Pharma, directs all business operations and strategic initiatives within the Korean market. Overseeing the local management team, the President of Korea Companies ensures that the company's distribution and commercial services meet the specific regulatory and market requirements of Korea. This role involves building strong relationships with local healthcare stakeholders and pharmaceutical partners to drive business growth. Dr Franck collaborates with the regional executive team to align Korean operations with the company's global mission. By focusing on market expansion and service quality, the President of Korea Companies enhances the company's competitive position in the region. Through the effective management of local resources, Franck ensures that the business remains agile and responsive to the unique demands of the Korean healthcare sector. Ultimately, the President of Korea Companies drives the company's success and market leadership within Korea.

Luiz Enriquez, the Chief Technology Officer at Zuellig Pharma, architects the digital infrastructure required to modernize healthcare distribution and commercial services. Overseeing the development of advanced data analytics and supply chain software, the Chief Technology Officer ensures that digital tools enhance operational efficiency across the entire Asian network. This leadership role involves driving the adoption of emerging technologies to improve patient engagement and service delivery. Luiz Enriquez collaborates with other C-suite leaders to integrate digital solutions into the core business model, ensuring seamless connectivity between manufacturers and healthcare providers. By prioritizing cybersecurity and data integrity, the Chief Technology Officer protects the company's digital assets while enabling scalable growth. Through the implementation of innovative platforms, Enriquez transforms traditional healthcare services into tech-enabled experiences. Ultimately, the Chief Technology Officer secures the company's position at the forefront of digital healthcare transformation.

Avraham Raz, the Vice President COMMERCIAL EXCELLENCE and CHIEF OF STAFF at Zuellig Pharma, directs initiatives to improve commercial performance and supports the executive office in strategic planning. Overseeing the implementation of sales effectiveness programs, the Vice President COMMERCIAL EXCELLENCE and CHIEF OF STAFF ensures that commercial teams possess the tools and strategies needed to drive market penetration. This role involves coordinating cross-functional projects to align business units with the company's overarching goals. Avraham Raz collaborates with the CEO to manage executive priorities and facilitate organizational communication. By focusing on commercial optimization, the Vice President COMMERCIAL EXCELLENCE and CHIEF OF STAFF enhances the company's ability to capture market share in the healthcare services industry. Through the integration of data-driven sales strategies, Raz improves overall commercial outcomes. Ultimately, the Vice President COMMERCIAL EXCELLENCE and CHIEF OF STAFF drives the company's commercial success through strategic alignment and operational excellence.

Avi Raz, the Vice President Commercial Excellence and Chief of Staff, Zuellig Pharma Commercialization at Zuellig Pharma, manages the commercialization strategy for the company's specialized service offerings. Overseeing the development of go-to-market plans, the Vice President Commercial Excellence and Chief of Staff, Zuellig Pharma Commercialization ensures that new services reach target markets effectively. This role involves analyzing customer needs and market dynamics to refine the commercial approach for healthcare products. Avi Raz collaborates with the commercialization team to drive revenue growth and expand the company's service footprint. By focusing on commercial excellence, the Vice President Commercial Excellence and Chief of Staff, Zuellig Pharma Commercialization enhances the value proposition offered to pharmaceutical partners. Through the coordination of strategic initiatives, Raz ensures that the commercialization division remains agile and responsive to market changes. Ultimately, the Vice President Commercial Excellence and Chief of Staff, Zuellig Pharma Commercialization drives the company's commercial growth and market impact.

Pucknalin Bulakul, the Chief Operations Officer at Zuellig Pharma, directs the strategic management of operational assets and service delivery models. Overseeing the optimization of service workflows, the Chief Operations Officer ensures that the company's healthcare services are delivered with maximum efficiency and quality. This role involves managing the integration of new operational technologies to improve service speed and reliability across the regional network. Pucknalin Bulakul collaborates with the executive team to refine operational strategies that support the company's growth objectives. By focusing on the scalability of service operations, the Chief Operations Officer enhances the company's ability to meet the diverse needs of healthcare providers. Through the implementation of continuous improvement initiatives, Bulakul drives operational excellence across the organization. Ultimately, the Chief Operations Officer secures the company's ability to provide high-quality healthcare services by maintaining a robust and efficient operational framework.